VitaStem current market price is $0.0642 with a 24 hour trading volume of $11,641. The total available supply of VitaStem is 3,191.80K VITASTEM with a maximum supply of 10.00M VITASTEM. It has secured Rank 5884 in the cryptocurrency market with a marketcap of $203.26K. The VITASTEM price is -3.62% down in the last 24 hours.
The lowest price of the VitaStem is $0.0637 & the highest price is $0.0687 in the last 24 hours. Live VitaStem prices from all markets and VITASTEM coin market Capitalization. Stay up to date with the latest VitaStem price movements. Check our coin stats data and see when there is an opportunity to buy or sell VitaStem at best price in the market.
#5884
$0.0642
$-0 -3.62%
$0.0637 / $0.0687
$203.26K -2.44%
$11,641
3,191.80K VITASTEM
10.00M VITASTEM
Want to convert more cryptocurrencies?
-3.62%
-18.28%
-22.44%
-46.21%
-73.94%
0%
Compare live prices of VitaStem on top exchanges.
| # | Exchange | Pair | Price | Volume (24h) |
|---|---|---|---|---|
| Uniswap V3 (Base) | 0X5D4D2.../0X226A2... | $0.0642 | $11,578 | |
| Uniswap V4 (Base) | 0X5D4D2.../0X83358... | $0.0650 | $59 | |
| Uniswap V3 (Base) | 0X5D4D2.../0X83358... | $0.0650 | $4 |
VitaSTEM — The first AI-enabled longevity project and inaugural IP-Token launched by Aubrai, VitaDAO’s decentralized scientific agent. After six months of deep research on public and proprietary single-cell RNA-seq and multi-omics datasets, our scientific research team analyzed more than 850,000 human hematopoietic stem cell transcriptomes from donors aged 23–91 (both male and female). This effort uncovered 100+ high-potential rejuvenation target genes and revealed critical drivers of decline such as RhoA hyperactivation, CD38 upregulation, and CCR9 downregulation. Rather than treating HSC aging as a single defect, Aubrai recognized it as convergent damage across interconnected systems, generating a comprehensive multi-modal, five-phase rejuvenation protocol targeting transcriptional stress, metabolic dysfunction, and epigenetic drift in parallel. The agent shortlisted target genes using insights from thousands of peer-reviewed publications and private data and also optimized experimental protocols to guide in vitro and upcoming pre-clinical testing. For the first time, human researchers and AI Agents collaborate as co-scientists in the creation of pioneering scientific IP.
https://app.bio.xyz/ipts/vitastem
https://basescan.org/address/0x5d4d258144bc954aefc00ee6cbda0433b1b2dcd3
